New Drug a Weapon Against Advanced Melanoma: Study
Compared to Yervoy, nivolumab more than doubled time to disease progression, researchers foundContinue Reading
Compared to Yervoy, nivolumab more than doubled time to disease progression, researchers foundContinue Reading
Study finds effect seems to extend to people exposed to secondhand smoke, tooContinue Reading
Finding might one day help doctors better choose patients to receive Keytruda, study saysContinue Reading
LAM affects mostly women of child-bearing ageContinue Reading
Study found people with highest dose were 25 percent less likely to develop eye conditionContinue Reading
Syndrome affects up to 15 percent of U.S. adultsContinue Reading
Both treat diarrhea that can strike some with the gastrointestinal disorderContinue Reading
Both should be treated at the same time, researchers sayContinue Reading
But those with three or four heart risk factors may benefit from getting beta-blockersContinue Reading
Experimental treatment might benefit people who forget to take meds, researcher saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.